These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

231 related items for PubMed ID: 428427

  • 1. Effects of baclofen on striatal 5-HT mediated by the nigrostriatal dopamine system.
    Waldmeier PC, Feldtrauer JJ, Kam R, Stöcklin K.
    Eur J Pharmacol; 1979 Mar 01; 54(3):279-87. PubMed ID: 428427
    [Abstract] [Full Text] [Related]

  • 2. In vivo release of dopamine from rat striatum, substantia nigra and prefrontal cortex: differential modulation by baclofen.
    Santiago M, Machado A, Cano J.
    Br J Pharmacol; 1993 Jul 01; 109(3):814-8. PubMed ID: 7689406
    [Abstract] [Full Text] [Related]

  • 3. Effects of baclofen and gamma-hydroxybutyrate on rat striatal and mesolimbic 5-HT metabolism.
    Waldmeier PC, Fehr B.
    Eur J Pharmacol; 1978 May 15; 49(2):177-84. PubMed ID: 658133
    [Abstract] [Full Text] [Related]

  • 4. Kainic acid-induced changes of serotonin and dopamine metabolism in the striatum and substantia nigra of the rat.
    Sperk G, Berger M, Hörtnagl H, Hornykiewicz O.
    Eur J Pharmacol; 1981 Sep 24; 74(4):279-86. PubMed ID: 6170518
    [Abstract] [Full Text] [Related]

  • 5. Neurochemical changes in the substantiae nigrae and caudate nuclei following acute unilateral intranigral infusions of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
    Sirinathsinghji DJ, Whittington PE, Audsley AR.
    Brain Res; 1986 Dec 10; 399(2):339-45. PubMed ID: 2435361
    [Abstract] [Full Text] [Related]

  • 6. Effects of acute administration of SCH 23390 on dopamine and serotonin turnover in major dopaminergic areas and mesencephalic raphe nuclei--comparison with ritanserin.
    Lappalainen J, Hietala J, Koulu M, Sjöholm B, Syvälahti E.
    Prog Neuropsychopharmacol Biol Psychiatry; 1991 Dec 10; 15(6):861-72. PubMed ID: 1722342
    [Abstract] [Full Text] [Related]

  • 7. Acute effects of intranigral application of MPP+ on nigral and bilateral striatal release of dopamine simultaneously recorded by microdialysis.
    Santiago M, Rollema H, de Vries JB, Westerink BH.
    Brain Res; 1991 Jan 11; 538(2):226-30. PubMed ID: 1707325
    [Abstract] [Full Text] [Related]

  • 8. Effects of baclofen on dopamine metabolism and interaction with neuroleptic effects.
    Waldmeier PC, Maitre L.
    Eur J Pharmacol; 1978 Jan 15; 47(2):191-200. PubMed ID: 23298
    [Abstract] [Full Text] [Related]

  • 9. Serotonergic sprouting is induced by dopamine-lesion in substantia nigra of adult rat brain.
    Zhou FC, Bledsoe S, Murphy J.
    Brain Res; 1991 Aug 09; 556(1):108-16. PubMed ID: 1718555
    [Abstract] [Full Text] [Related]

  • 10. On the use of multiple probe insertions at the same site for repeated intracerebral microdialysis experiments in the nigrostriatal dopamine system of rats.
    Camp DM, Robinson TE.
    J Neurochem; 1992 May 09; 58(5):1706-15. PubMed ID: 1373176
    [Abstract] [Full Text] [Related]

  • 11. Increased dopamine release from striata of rats after unilateral nigrostriatal bundle damage.
    Zhang WQ, Tilson HA, Nanry KP, Hudson PM, Hong JS, Stachowiak MK.
    Brain Res; 1988 Oct 04; 461(2):335-42. PubMed ID: 3141002
    [Abstract] [Full Text] [Related]

  • 12. Efficacy of brain-derived neurotrophic factor and neurotrophin-3 on neurochemical and behavioral deficits associated with partial nigrostriatal dopamine lesions.
    Altar CA, Boylan CB, Fritsche M, Jones BE, Jackson C, Wiegand SJ, Lindsay RM, Hyman C.
    J Neurochem; 1994 Sep 04; 63(3):1021-32. PubMed ID: 7519657
    [Abstract] [Full Text] [Related]

  • 13. Characterization of dopamine release in the substantia nigra by in vivo microdialysis in freely moving rats.
    Robertson GS, Damsma G, Fibiger HC.
    J Neurosci; 1991 Jul 04; 11(7):2209-16. PubMed ID: 1712381
    [Abstract] [Full Text] [Related]

  • 14. Effects of acute GR38032F (odansetron), a 5-HT3 receptor antagonist, on dopamine and serotonin metabolism in mesolimbic and nigrostriatal dopaminergic neurons.
    Koulu M, Sjöholm B, Lappalainen J, Virtanen R.
    Eur J Pharmacol; 1989 Oct 10; 169(2-3):321-4. PubMed ID: 2530097
    [Abstract] [Full Text] [Related]

  • 15. Cholinergic stimulation of substantia nigra: abolition of carbachol-induced eating by unilateral 6-hydroxydopamine lesion of nigrostriatal dopamine neurones.
    Parker GC, Rugg EL, Winn P.
    Exp Brain Res; 1991 Oct 10; 87(3):597-603. PubMed ID: 1723691
    [Abstract] [Full Text] [Related]

  • 16. A microdialysis study on striatal dopamine, 5-HT and metabolites in conscious rats after various treatments: evidence for extravesicular release of dopamine.
    Wong PT, Teo WL, Lee T.
    Neuroreport; 1993 Oct 25; 5(1):53-6. PubMed ID: 7506588
    [Abstract] [Full Text] [Related]

  • 17. Preservation of dopamine release in the denervated striatum.
    Altar CA, Marien MR.
    Neurosci Lett; 1989 Jan 30; 96(3):329-34. PubMed ID: 2497410
    [Abstract] [Full Text] [Related]

  • 18. Baclofen and gamma-hydroxybutyrate: similar effects on cerebral dopamine neurones.
    Da Prada M, Keller HH.
    Life Sci; 1976 Oct 15; 19(8):1253-63. PubMed ID: 994724
    [No Abstract] [Full Text] [Related]

  • 19. Effect of naloxone on morphine-induced changes in striatal dopamine metabolism and glutamate, ascorbic acid and uric acid release in freely moving rats.
    Enrico P, Mura MA, Esposito G, Serra P, Migheli R, De Natale G, Desole MS, Miele M, Miele E.
    Brain Res; 1998 Jun 22; 797(1):94-102. PubMed ID: 9630540
    [Abstract] [Full Text] [Related]

  • 20. Intranigral GABAergic drug effects on striatal dopamine activity.
    Sperber EF, Wurpel JN, Sharpless NS, Moshé SL.
    Pharmacol Biochem Behav; 1989 Apr 22; 32(4):1067-70. PubMed ID: 2477863
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.